Stocks and Investing Stocks and Investing
Fri, July 26, 2024

Raghuram Selvaraju Reiterated (AQST) at Strong Buy and Held Target at $9 on, Jul 26th, 2024


Published on 2024-10-28 12:48:18 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Aquestive Therapeutics, Inc." (AQST) at Strong Buy and Held Target at $9 on, Jul 26th, 2024.

Raghuram has made no other calls on AQST in the last 4 months.



There are 4 other peers that have a rating on AQST. Out of the 4 peers that are also analyzing AQST, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Raghuram


  • Jason Butler of "JMP Securities" Reiterated at Buy and Held Target at $9 on, Wednesday, June 26th, 2024
  • Roanna Ruiz of "Leerink Partners" Initiated at Buy and Held Target at $8 on, Friday, May 10th, 2024
  • David Amsellem of "Piper Sandler" Initiated at Buy and Held Target at $10 on, Thursday, April 11th, 2024
  • Gary Nachman of "Raymond James" Initiated at Buy and Held Target at $7 on, Thursday, March 28th, 2024

Contributing Sources